Touchon Pascal 4
4 · Atara Biotherapeutics, Inc. · Filed Aug 14, 2024
Insider Transaction Report
Form 4
Touchon Pascal
Director
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2024-08-12−9,000→ 0 totalExercise: $510.75Exp: 2029-06-24→ Common Stock (9,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2024-08-12−9,680→ 0 totalExercise: $303.75Exp: 2030-02-28→ Common Stock (9,680 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2024-08-12−7,075→ 0 totalExercise: $427.63Exp: 2031-02-28→ Common Stock (7,075 underlying)
Footnotes (4)
- [F1]25% of the shares subject to the option vested on June 24, 2020, and the remaining shares vested in equal monthly installments over the following 36 months.
- [F2]1/48th of the shares subject to the stock option vested and became exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.
- [F3]1/48th of the shares subject to the stock option vested and became exercisable each month with the initial installment vesting on April 1, 2021, subject to the reporting person's continuous service.
- [F4]This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration.